Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Watson Expects To Hold Nicotine Gum Market Position Despite Perrigo Entry

This article was originally published in The Tan Sheet

Executive Summary

Watson does not expect an ongoing sales lag as a result of Perrigo's recent entry into the generic nicotine gum market

You may also be interested in...

Cough/Cold Sales Shortfall Has Perrigo Looking To Smoking Cessation

Perrigo expects nicotine replacement gum product revenue to compensate in part for lagging winter cough/cold sales in the second half of its fiscal year

Perrigo chewses smoking cessation

Perrigo receives ANDA generic drug approvals for over-the-counter nicotine polacrilex gum in 2mg and 4 mg doses Sept. 16. The approvals total six, with regular, mint and orange flavors for each dose. The approvals build on the firm's existing smoking cessation portfolio of nicotine replacement patch products (1"The Tan Sheet" Nov. 15, 1999, p. 13)....

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts